Glaucoma Surgery
Glaucoma Surgery
Glaucoma Surgery
Glaucoma Surgery
What Is Glaucoma?
Glaucoma is progressive, permanent vision loss typically associated with high intraocular pressure (IOP), or elevated pressure inside the eye. Glaucoma damages the nerve that connects the eye to the brain. Lowering the IOP typically prevents glaucoma from worsening and can be accomplished with eye drops, laser, or surgical techniques.
Selective Laser Trabeculoplasty (SLT)
Selective laser trabeculoplasty (SLT) is an outpatient laser procedure in which your physician applies laser energy to the trabecular meshwork inside your eye. The trabecular meshwork is the main outflow of the eye. Applying energy to this area improves outflow and lowers the intraocular pressure. This treatment can sometimes be repeated to improve the efficacy or duration of results.
We use an Ellex Tango laser that provides precise treatments for our glaucoma patients.
iStent inject
Minimally-invasive Glaucoma Surgery
iStent inject is a minimally-invasive glaucoma surgery or MIGS. MIGS provides a unique opportunity to lower the intraocular pressure and reduce dependence on glaucoma medications in a safe and controlled manner. iStent inject is approved for implantation at the time of cataract surgery, treating both cataracts and glaucoma with one procedure.
Hydrus Microstent
Minimally-invasive Glaucoma Surgery
Another MIGS, the Hydrus Microstent is now being performed at our next-door surgery center, Texoma Outpatient Surgery Center. We are proud to be the first clinic or surgery center in Wichita Falls to offer this great service.
Similar to iStent Inject, the Hydrus treats glaucoma at the time of cataract surgery, helping lower the intraocular pressure and possibly reduce the number of glaucoma eye drops needed to control the intraocular pressure.
In the HORIZON study, the Hydrus Microstent showed the largest reduction in intraocular pressure compared to cataract surgery alone of any other MIGS pivotal trial.*
*Samuelson TW, Chang DF, Marquis R, et al; HORIZON Investigators. A Schlemm canal microstent for intraocular pressure reduction in primary open-angle glaucoma and cataract: The HORIZON Study. Ophthalmology. 2019;126:29-37.
For more information about the Hydrus Microstent, visit www.ivantisinc.com/patients.
© 2024 North Texas Ophthalmology Associates. All rights Reserved | Accessibility Statement| Privacy Policy | Language Policy
Powered by:
